Novo Holdings, the investment arm of the Novo Nordisk Foundation, has 77% of voting shares in Novo Nordisk, which is known for producing blockbuster obesity drug Wegovy and diabetes treatment Ozempic.
Novo Holdings, the controlling
shareholder of Danish obesity drugmaker Novo Nordisk,
said on Wednesday it plans to invest around $200 million in
quantum computing startups. The company,.
Novo Nordisk Owner to Invest $200 Million in Quantum Computing Startups usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
Animals - Balancing available feed - Local Matters localmatters.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localmatters.co.nz Daily Mail and Mail on Sunday newspapers.